Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Montalescot

Showing results (11-20 of 631) with videos related to

Pageof 64
Sort By:
JACC. Cardiovascular Interventions|June 20, 2015
Reply: Lights and Shadows of Antiplatelet Therapy in Primary Percutaneous Coronary InterventionUwe Zeymer, Gilles Montalescot
European Heart Journal|May 16, 2018
The times they are a changin'Nadjib Hammoudi, Gilles Montalescot
European Heart Journal|December 10, 2024
Oral P2Y12 inhibitor pre-treatment for percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: evolving notions in ESC guidelinesMarco Roffi, Gilles Montalescot
European Heart Journal|October 23, 2021
The Cornelian dilemma† of quitting DAPTZuzana Motovska, Gilles Montalescot
Archives of Cardiovascular Diseases|June 20, 2012
Anticoagulant for primary percutaneous coronary intervention - the last dance for unfractionated heparin?Johanne Silvain, Gilles Montalescot
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2023
Clopidogrel: still king of the ring for elective percutaneous coronary intervention!Gilles Montalescot, Arnaud Ferrante
The Lancet. Respiratory Medicine|June 14, 2021
RAS inhibition and COVID-19: more questions than answers?Mathieu Kerneis, Gilles Montalescot
Journal of the American College of Cardiology|February 2, 2019
Interventional Standby for CABG Surgery: The Reverse ParadigmPaul Guedeney, Gilles Montalescot
European Heart Journal|January 5, 2016
The year in cardiology 2015: acute coronary syndromesGilles Montalescot, Filippo Crea
Journal of Thoracic Disease|March 31, 2018
Heart-breaking aspirin interruptionMichel Zeitouni, Gilles Montalescot
Pageof 64

Showing results (11-20 of 631) with videos related to

Sort By:
Pageof 64
JACC. Cardiovascular Interventions|June 20, 2015
Reply: Lights and Shadows of Antiplatelet Therapy in Primary Percutaneous Coronary InterventionUwe Zeymer, Gilles Montalescot
European Heart Journal|May 16, 2018
The times they are a changin'Nadjib Hammoudi, Gilles Montalescot
European Heart Journal|December 10, 2024
Oral P2Y12 inhibitor pre-treatment for percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: evolving notions in ESC guidelinesMarco Roffi, Gilles Montalescot
European Heart Journal|October 23, 2021
The Cornelian dilemma† of quitting DAPTZuzana Motovska, Gilles Montalescot
Archives of Cardiovascular Diseases|June 20, 2012
Anticoagulant for primary percutaneous coronary intervention - the last dance for unfractionated heparin?Johanne Silvain, Gilles Montalescot
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 20, 2023
Clopidogrel: still king of the ring for elective percutaneous coronary intervention!Gilles Montalescot, Arnaud Ferrante
The Lancet. Respiratory Medicine|June 14, 2021
RAS inhibition and COVID-19: more questions than answers?Mathieu Kerneis, Gilles Montalescot
Journal of the American College of Cardiology|February 2, 2019
Interventional Standby for CABG Surgery: The Reverse ParadigmPaul Guedeney, Gilles Montalescot
European Heart Journal|January 5, 2016
The year in cardiology 2015: acute coronary syndromesGilles Montalescot, Filippo Crea
Journal of Thoracic Disease|March 31, 2018
Heart-breaking aspirin interruptionMichel Zeitouni, Gilles Montalescot
Pageof 64